Professional Summary

Professional Overview

Eric Kendig is an experienced Regulatory Affairs executive with a strong track record of driving strategic initiatives and delivering tangible results for pharmaceutical companies. As the VP, Head of Regulatory Affairs at scPharmaceuticals, he leverages his deep industry expertise to navigate complex regulatory landscapes and ensure compliance across the organization's product portfolio.

Experience Summary

Current Role

In his current role as VP, Head of Regulatory Affairs at scPharmaceuticals, Eric is responsible for leading the company's regulatory strategy and overseeing all regulatory affairs activities. He collaborates closely with cross-functional teams to ensure timely submissions, successful regulatory approvals, and ongoing compliance with evolving industry standards. Under his leadership, the regulatory affairs department has achieved significant milestones, including the successful submission and approval of multiple new drug applications.

Career Progression

Prior to joining scPharmaceuticals, Eric held various regulatory affairs roles at Camargo Pharmaceutical Services, where he progressively advanced from Senior Scientific & Regulatory Manager to Director of Regulatory Science and ultimately Vice President of Regulatory Strategy. In these positions, he demonstrated his ability to navigate complex regulatory environments, provide strategic guidance, and deliver impactful solutions for clients.

Earlier in his career, Eric gained valuable research experience through a postdoctoral fellowship at the University of Cincinnati and graduate research positions at various institutions.

Academic Background

Eric holds a Ph.D. in Pharmaceutical Sciences from the University of Cincinnati, where he specialized in drug delivery and formulation development. His academic achievements include several peer-reviewed publications and presentations at industry conferences.

Areas of Expertise

• Regulatory strategy and compliance

• New drug application (NDA) and biologics license application (BLA) submissions

• Investigational new drug (IND) filings and clinical trial management

• International regulatory affairs, including EU and Asia-Pacific markets

• Cross-functional collaboration and stakeholder management

• Leadership in highly regulated environments

Professional Impact

Throughout his career, Eric has established himself as a respected thought leader in the pharmaceutical industry. He has contributed to the development of innovative drug products, ensuring they meet rigorous regulatory requirements while maintaining a strong focus on patient safety and efficacy. Eric's expertise and strategic insights have been instrumental in helping his clients and employers navigate complex regulatory landscapes and achieve their business objectives.

Conclusion

With over a decade of experience in the pharmaceutical industry, Eric Kendig is a seasoned Regulatory Affairs executive committed to driving innovation and excellence. In his current role at scPharmaceuticals, he continues to leverage his deep industry knowledge and proven track record to guide the company's regulatory strategy and ensure the successful development and commercialization of its drug products.